Andrew S McLean1, Nathan Price2, Stephen Graves3, Alesha Hatton4, Fraser J Taylor2. 1. Department of Orthopaedics, Gold Coast University Hospital, Gold Coast, QLD, Australia. Electronic address: Andrew.McLean2@health.qld.gov.au. 2. Department of Orthopaedics, Gold Coast University Hospital, Gold Coast, QLD, Australia. 3. Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, SA, Australia. 4. South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Abstract
BACKGROUND: There is no consensus as to the treatment of proximal humeral fractures (PHFs), particularly in elderly patients. There is increasing evidence that nonoperative management may have similar functional outcomes to operative management, which is potentially conflicting with increasingly improved surgical techniques and implants. The aim of this study was to investigate the changes in the incidence and management of PHFs across Australia over a 10-year period. MATERIALS AND METHODS: We retrospectively reviewed all hospitalizations of patients with PHFs from 2 Australian national health care databases from 2008 to 2017. We recorded the incidence of PHFs and annual utilization rates of commonly used treatment options including nonoperative management, hemiarthroplasty (HA), reverse total shoulder arthroplasty (RTSA), and open reduction-internal fixation (ORIF). RESULTS: The incidence of PHFs increased from 26.8 per 100,000 person-years in 2008 to 45.7 per 100,000 person-years in 2017. There was a decrease in operative management from 2008 to 2017, with 32.5% and 22.8% of all PHFs treated operatively in 2008 and 2017, respectively (P = .001). ORIF use decreased significantly from 76.6% to 72.6% (P = .004). RTSA use increased significantly from 4.1% to 24.5% (P < .001). HA use decreased significantly from 19.3% to 3% (P < .001). CONCLUSIONS: Whereas the incidence of PHFs increased, the operative management of PHFs decreased significantly from 2008 to 2017, particularly in patients aged 65 years or older. This decrease in operative management was in part due to a significant decrease in ORIF and HA use in patients aged 65 years or older. There was a significant increase in RTSA use.
BACKGROUND: There is no consensus as to the treatment of proximal humeral fractures (PHFs), particularly in elderly patients. There is increasing evidence that nonoperative management may have similar functional outcomes to operative management, which is potentially conflicting with increasingly improved surgical techniques and implants. The aim of this study was to investigate the changes in the incidence and management of PHFs across Australia over a 10-year period. MATERIALS AND METHODS: We retrospectively reviewed all hospitalizations of patients with PHFs from 2 Australian national health care databases from 2008 to 2017. We recorded the incidence of PHFs and annual utilization rates of commonly used treatment options including nonoperative management, hemiarthroplasty (HA), reverse total shoulder arthroplasty (RTSA), and open reduction-internal fixation (ORIF). RESULTS: The incidence of PHFs increased from 26.8 per 100,000 person-years in 2008 to 45.7 per 100,000 person-years in 2017. There was a decrease in operative management from 2008 to 2017, with 32.5% and 22.8% of all PHFs treated operatively in 2008 and 2017, respectively (P = .001). ORIF use decreased significantly from 76.6% to 72.6% (P = .004). RTSA use increased significantly from 4.1% to 24.5% (P < .001). HA use decreased significantly from 19.3% to 3% (P < .001). CONCLUSIONS: Whereas the incidence of PHFs increased, the operative management of PHFs decreased significantly from 2008 to 2017, particularly in patients aged 65 years or older. This decrease in operative management was in part due to a significant decrease in ORIF and HA use in patients aged 65 years or older. There was a significant increase in RTSA use.
Authors: Bradley S Schoch; Joseph J King; Thomas W Wright; Stephen F Brockmeier; Jean-David Werthel; Brian C Werner Journal: Eur J Orthop Surg Traumatol Date: 2022-03-10
Authors: Miguel Relvas Silva; Daniela Linhares; Maria João Leite; Bernardo Nunes; João Torres; Nuno Neves; Manuel Ribeiro Silva Journal: JSES Int Date: 2022-01-24
Authors: Maximilian Willauschus; Linus Schram; Michael Millrose; Johannes Rüther; Kim Loose; Hermann Josef Bail; Markus Geßlein Journal: J Clin Med Date: 2022-04-30 Impact factor: 4.964
Authors: Jonathan W Cheah; Edward L Baldwin; Jeffrey A O'Donnell; Gregory Pereira; Danica D Vance; Tally E Lassiter; Oke A Anakwenze Journal: JSES Int Date: 2020-08-26